Young women can get HPV without intercourse

Article

At their first dose of quadrivalent vaccine for human papillomavirus (HPV), more than 11% of young women aged 13 to 21 years who had never had sexual intercourse were already infected with 1 or more strains of HPV, a study has found.

At their first dose of quadrivalent vaccine for human papillomavirus (HPV), more than 11% of young women aged 13 to 21 years who had never had sexual intercourse were already infected with 1 or more strains of HPV, a study has found.

Researchers evaluated 259 young women recruited from an adolescent primary care clinic of whom 190 (73.4%) were sexually experienced (had had vaginal or anal intercourse). Nine (13%) of the 69 inexperienced study participants reported sexual contact (genital, skin-to-skin contact only). Eight of the sexually inexperienced participants (11.6%) were infected with HPV, as were 133 (70%) of the sexually experienced participants.

Of the sexually inexperienced participants, 2 (2.9%) were infected with HPV-16, 2 (2.9%) with HPV-68, none with HPV-18, and 3 (4.3%) with any vaccine-type HPV. Five patients had more than 1 HPV type (2 with 2 types and 3 with 3 types).

Inexperienced girls and women may have contracted HPV by hand-to-genital or genital skin-to-skin-only contact, the researchers speculate. They note that their study shows that sexually inexperienced girls and young women are vulnerable to HPV infection and it supports recommendations that 11- to 12-year-old girls be targeted for HPV immunization. Vaccination should not be delayed because a girl is not sexually active, they emphasize.

Read other articles in this issue of Special Delivery.

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.